Peroxisome proliferator activated receptors, fatty acids and muscle insulin resistance

Journal of the Royal Society of Medicine, Supplement

Volumn 95, Issue 42, 2002, Pages 14-22

  Kraegen, Edward ^a   Cooney, Gregory ^a   Ye, Ji Ming ^a   Furler, Stuart ^a  

^a ST VINCENT S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ACYL COENZYME A; ANTILIPEMIC AGENT; DIACYLGLYCEROL; FATTY ACID; GLUCOSE; GLYCOGEN; HEPARIN; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; LONG CHAIN FATTY ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN KINASE C; TRIACYLGLYCEROL;

ADIPOSE TISSUE; ADULT; AGED; ANIMAL MODEL; CONFERENCE PAPER; CONTROLLED STUDY; DIABETES MELLITUS; DYSLIPIDEMIA; ENZYME ACTIVITY; FATTY ACID METABOLISM; FEMALE; GENE EXPRESSION; GLUCOSE METABOLISM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID METABOLISM; LIPODYSTROPHY; MALE; MOUSE; MUSCLE BIOPSY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; RAT; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; TRANSGENIC MOUSE;

ACYL COENZYME A; CELL COMMUNICATION; CELL MEMBRANE; FATTY ACIDS; FEMALE; GENE EXPRESSION; HUMANS; INSULIN RESISTANCE; LIPID METABOLISM; MALE; MUSCLE, SKELETAL; RECEPTORS, CYTOPLASMIC AND NUCLEAR; TRANSCRIPTION FACTORS;

EID: 0036347495     PISSN: 02675331     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (101)

1. Development of muscle insulin resistance after liver insulin resistance in high-fat-fed rats
2. Influence of dietary fat composition on development of insulin resistance in rats
3. Fish oil prevents insulin resistance induced by high-fat feeding in rats
4. Direct antidiabetic effect of leptin through TG depletion of tissues
5. Development of insulin resistance in the jcr-La-Cp rat - Role of triacylglycerols and effects of Medica 16
6. Effects of clenbuterol on insulin resistance in conscious obese Zucker rats
7. Prolonged inhibition of muscle carnitine palmitoyltransferase-1 promotes intramyocellular lipid accumulation and insulin resistance in rats
8. Diet-induced muscle insulin resistance in rats is ameliorated by acute dietary lipid withdrawal or a single bout of exercise - Parallel relationship between insulin stimulation of glucose uptake and suppression of long-chain fatty acyl-CoA
9. The insulin sensitizer, BRL 49653, reduces systemic FA supply and utilization and tissue lipid availability in the rat
10. Peroxisome proliferator-activated receptor (PPAR)-alpha activation lowers muscle lipids and improves insulin sensitivity in high fat-fed rats - Comparison with PPAR-gamma activation
11. Carbohydrate and lipid metabolism of skeletal muscle in type 2 diabetic patients
12. Intramuscular TG and muscle insulin sensitivity - Evidence for a relationship in nondiabetic subjects
13. Skeletal muscle TG levels are inversely related to insulin action
14. Subcutaneous abdominal fat and thigh muscle composition predict insulin sensitivity independently of visceral fat
15. Measurement of intracellular TG stores by H spectroscopy: Validation in vivo
16. Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: A H-1 NMR spectroscopy study
17. Association of increased intramyocellular lipid content with insulin resistance in lean nondiabetic offspring of type 2 diabetic subjects
18. Relation of TG stores in skeletal muscle cells to central obesity and insulin sensitivity in European and South Asian men
19. Intramyocellular lipid is associated with resistance to in vivo insulin actions on glucose uptake, antilipolysis, and early insulin signaling pathways in human skeletal muscle
20. Morphometric documentation of abnormal intramyocellular fat storage and reduced glycogen in obese patients with type II diabetes
21. Correlations between intramyocellular lipid, visceral fat and insulin sensitivity: A study of HIV positive subjects with and without peripheral lipodystrophy
22. Long-chain acyl-CoA esters as indicators of lipid metabolism and insulin sensitivity in rat and human muscle
23. Independent influences of central fat and skeletal muscle lipids on insulin sensitivity
24. In vivo determination of intra-myocellular lipids in human muscle by means of localized H-1-MR-spectroscopy
25. Intramyocellular TG content is a determinant of in vivo insulin resistance in humans - A H-1-C-13 nuclear magnetic resonance spectroscopy assessment in offspring of type 2 diabetic parents
26. Analysis of acyl-coenzyme A esters in biological samples
27. Fuel selection in human skeletal muscle in insulin resistance - A reexamination
28. Muscle TG utilisation during exercise: Effect of training
29. Design of the oxygen and substrate pathways. V. Structural basis of vascular substrate supply to muscle cells
30. Skeletal muscle lipid content and insulin resistance: Evidence for a paradox: In endurance-trained athletes
31. Heterogeneity of insulin action in individual muscles in vivo: Euglycemic clamp studies in rats
32. Regional differences in intramyocellular lipids in humans observed by in vivo H-1-MR spectroscopic imaging
33. Role of FAs in the pathogenesis of insulin resistance and NIDDM
34. Five hour FA elevation increases muscle lipids and impairs glycogen synthesis in the rat
35. Free FA-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade
36. Effects of fat on insulin stimulated carbohydrate metabolism in normal men
37. Mechanisms of FA induced inhibition of glucose uptake
38. Interaction between glucose and free FA metabolism in human skeletal muscle
39. Prolonged suppression of glucose metabolism causes insulin resistance in rat skeletal muscle
40. C-13 and P-31 NMR studies on the effects of increased plasma free FAs on intramuscular glucose metabolism in the awake rat
41. Effects of high fatfeeding to rats on the interrelationship of body weight, plasma insulin, and fatty acyl-coenzyrne-A esters in liver and skeletal muscle
42. Muscle-specific overexpression of FAT/CD36 enhances FA oxidation by contracting muscle, reduces plasma TGs and FAs, and increases plasma glucose and insulin
43. Overexpressing human lipoprotein lipase in mouse skeletal muscle is associated with insulin resistance
44. The glucose fattyacid cycle: Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus
45. Mechanisms of liver and muscle insulin resistance induced by chronic high-fat feeding
46. Skeletal muscle utilization of free FAs in women with visceral obesity
47. Role of long-chain fatty acyl-CoA esters in the regulation of metabolism and cell signalling
48. FA oxidation intermediates and the effect of fasting on oxidation in red and white skeletal muscle
49. Mechanism of palmityl coenzyne A inhibition of liver glycogen synthase
50. An allosteric model for the inhibition of glucokinase by long acyl coenzyme A
51. Fatty acyl-CoA esters inhibit glucose-6-phosphatase in rat liver microsomes
52. Inhibitory effects of long-chain acyl coenzyme A analogues on liver acetyl coenzyme A carboxylase
53. Acyl-CoA inhibition of hexokinase in rat and human skeletal muscle is a potential mechanism of lipid-induced insulin resistance
54. Interactions of impaired glucose transport and phosphorylation in skeletal muscle insulin resistance - A dose-response assessment using positron emission tomography
55. Alterations in the expression and cellular localization of protein kinase C isozymes epsilon and theta are associated with insulin resistance in skeletal muscle of the high-fat-fed rat
56. Muscle lipid accumulation and protein kinase C activation in the insulin-resistant chronically glucose-infused rat
57. Ceramide generation is sufficient to account for the inhibition of the insulin-stimulated PKB pathway in C2C12 skeletal muscle cells pretreated with palmitate
58. A high fat diet impairs stimulation of glucose transport in muscle - Functional evaluation of potential mechanisms
59. Enhanced insulin-stimulated activation of phosphatidylinositol 3-kinase in the liver of high-fat-fed rats
60. Defective insulin-induced GLUT4 translocation in skeletal muscle of high fat-fed rats is associated with alterations in both Akt/protein kinase B and atypical protein kinase C (zeta/lambda) activities
61. Thiazolidinedione treatment prevents free FA-induced insulin resistance in male Wistar rats
62. High-fat feeding impairs insulin-stimulated GLUT4 recruitment via an early insulin-signaling defect
63. Effects of free FAs on glucose transport and IRS-1 associated phosphatidylinositol 3-kinase activity
64. Regulation of gene expression by dietary fat
65. FA regulation of gene transcription
66. Fatty acyl-CoA thioesters are ligands of hepatic nuclear factor-4a
67. Preferential channeling of energy fuels toward fat rather than muscle during high free FA availability in rats
68. Dietary fats, membrane phospholipids and obesity
69. The relation between insulin sensitivity and the FA composition of skeletal-muscle phospholipids
70. FAs, TGs and syndromes of insulin resistance
71. Dietary fats and insulin action
72. Elevated intramyocellular lipid concentration in obese subjects is not reduced after diet and exercise training
73. Abdominal fat and insulin resistance in normal and overweight women - Direct measurements reveal a strong relationship in subjects at both low and high risk of NIDDM
74. Intra-abdominal fat is associated with decreased insulin sensitivity in healthy young men
75. Separate associations between visceral and subcutaneous adipose tissue distribution, insulin and glucose levels in obese women
76. Skeletal muscle glycolytic and oxidative enzyme capacities are determinants of insulin sensitivity and muscle composition in obese women
77. Glucose plus insulin regulate fat oxidation by controlling the rate of FA entry into the mitochondria
78. Metabolic interactions between glucose and FAs in humans
79. Malonyl-CoA, fuel sensing, and insulin resistance
80. Specific adaptations in muscle and adipose tissue in response to chronic systemic glucose oversupply in rats
81. Development and initial evaluation of a novel method for assessing tissue-specific plasma free FA utilization in vivo using (R)-2-bromopalmitate tracer
82. Enhanced efficiency of FA uptake in skeletal muscle of high-fat-fed rats contributes to intramuscular lipid accumulation and insulin resistance
83. Effects of an oral and intravenous fat load on adipose tissue and forearm lipid metabolism
84. Non-esterified FA metabolism and postprandial lipaemia
85. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR-gamma)
86. PPAR-gamma - Adipogenic regulator and thiazolidinedione receptor
87. Peroxisome proliferator-activated receptors and the regulation of lipid oxidation and adipogenesis
88. A new antidiabetic agent, BRL 49653, reduces lipid availability and improves insulin action and glucoregulation in the rat
89. Thiazolidinediones increase plasma-adipose tissue FFA exchange capacity and enhance insulin-mediated control of systemic EFA availability
90. A component of the in vivo insulin sensitizing action of pioglitazone does not depend on lipid lowering
91. Reversal of chronic alterations of skeletal muscle protein kinase C from fat-fed rats by BRL-49653
92. Acute and chronic effects of Troglitazone (CS-045) on isolated rat ventricular cardiomyocytes
93. Troglitazone regulation of glucose metabolism in human skeletal muscle cultures from obese type II diabetic subjects
94. Direct thiazolidinedione action on isolated rat skeletal muscle fuel handling is independent of peroxisome proliferator-activated receptor-gamma-mediated changes in gene expression
95. The hormone resistin links obesity to diabetes
96. You are what you secrete
97. Peroxisome proliferator-activated receptor alpha activators improve insulin sensitivity and reduce adiposity
98. A novel insulin sensitizer acts as a coligand for peroxisome proliferator-activated receptor-alpha (PPAR-alpha) and PPAR-gamma. Effect of PPARalpha activation on abnormal lipid metabolism in liver of Zucker fatty rats
99. AZ 242, a novel PPARa/g agonist, improves insulin sensitivity and increases FA uptake into white adipose tissue of high-fat-fed rats
100. NNC 61-0029: A novel PPAR ligand that enhances insulin sensitivity and reduces central adiposiw and tissue lipids in high-fat-fed rats